Cargando…
Blood-Based mRNA Tests as Emerging Diagnostic Tools for Personalised Medicine in Breast Cancer
SIMPLE SUMMARY: Molecular diagnostic tests can facilitate molecular classification of breast cancer and its clinical management, including prediction, prognosis, and selection of therapy. Messenger RNA tests can supplement the clinically widely used DNA genetic testing. For instance, they can offer...
Autores principales: | Čelešnik, Helena, Potočnik, Uroš |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954278/ https://www.ncbi.nlm.nih.gov/pubmed/36831426 http://dx.doi.org/10.3390/cancers15041087 |
Ejemplares similares
-
Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer
por: Čelešnik, Helena, et al.
Publicado: (2022) -
Gene Expression Profiles of Methyltransferases and Demethylases Associated with Metastasis, Tumor Invasion, CpG73 Methylation, and HPV Status in Head and Neck Squamous Cell Carcinoma
por: Goričan, Larisa, et al.
Publicado: (2023) -
MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines
por: Skok, Kristijan, et al.
Publicado: (2021) -
Integrated OMICS tools for personalised medicine
por: Borro, Marina, et al.
Publicado: (2015) -
Predictive diagnostics and personalised medicine in paediatrics
Publicado: (2011)